MedTrace Logo

Tricuspid Regurgitation in the ElderlY

NCT05784883 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2025-02-19

No results posted yet for this study

Summary

Tricuspid regurgitation (TR) is the second most common VHD after MR. Its prevalence also increases with age, with an estimated incidence of up to 6% in elderly population. When adjusted to age (among other confounders), survival is worse for patients with moderate and severe TR. We aim to explore the prevalence, mechanisms, and clinical implications of tricuspid valve regurgitation in elderly subjects screened at a tertiary center in Cairo, Egypt.

Conditions

  • Tricuspid Regurgitation

Interventions

DIAGNOSTIC_TEST

Echocardiography

A comprehensive 2- and 3-dimensional transthoracic echocardiography (TTE) assessment of the tricuspid valve and right side of the heart at baseline.

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Mohammad Abdelghani, MD, PhD · Al-Azhar Cardiology Research Institute

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2024-03-01
Completion
2029-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784883 on ClinicalTrials.gov